Enanta Pharmaceuticals
ENTA
#8289
Rank
C$0.46 B
Marketcap
C$15.94
Share price
-2.18%
Change (1 day)
-1.27%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: C$0.46 Billion

As of November 2026 Enanta Pharmaceuticals has a market cap of C$0.46 Billion. This makes Enanta Pharmaceuticals the world's 8289th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.46 B-30.3%
2025C$0.66 B264.37%
2024C$0.18 B-30.46%
2023C$0.26 B-79.98%
2022C$1.31 B-32.82%
2021C$1.95 B81.31%
2020C$1.07 B-32.57%
2019C$1.59 B-14.76%
2018C$1.87 B32.89%
2017C$1.41 B64.61%
2016C$0.85 B-0.43%
2015C$0.86 B-21.62%
2014C$1.09 B110.53%
2013C$0.52 B

End of Day market cap according to different sources

On Nov 10th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

C$0.46 Billion
by Nasdaq info icon info icon
C$0.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$960.19 B 206,739.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$438.01 B 94,254.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$737.96 B 158,867.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$197.33 B 42,408.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$518.47 B 111,587.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$182.35 B 39,182.04%๐Ÿ‡บ๐Ÿ‡ธ USA